Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces the appointments of Elizabeth Holt as Chief Business Officer (CBO) and Dr Mark ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Keighley Healthy Living was selected as one of ten winners of the 2025 GSK Impact Awards from a record number of entries. The awards, in their 28th year, are a joint venture by GSK and The King’s Fund ...

A charity dedicated to supporting mothers with postpartum psychosis has won a top national award. Action on Postpartum ...

A CHARITY operating across North Wales that provides support to adult survivors of childhood sexual abuse, has won a prestigious award.

A charity that is currently working at Bradford District Care NHS Foundation Trust, has won a prestigious award for its work in ...

Hannah Shead has been the chief executive officer (CEO) at Trevi for 13 years but said she was leaving the charity in "safe ...

based on targets nominated by GSK across multiple therapeutic areas. The deal comes hot on the heels of similar €250 million deal Exscientia signed with Sanofi in May. Andrew Hopkins ...

GSK’s approach to marketing content has had a major rethink in the last two years, under the new leadership of Emma Walmsley and Luke Miels. While the new CEO has made some high-profile changes ...

An ambitious London-based charity that has grown its impact across England has scooped one of this year’s GSK IMPACT Awards, ...

Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia Therapeutics’ endgame remains focused on pushing the therapy into a wide | ...